Free Trial

NexgenRx Q1 2024 Earnings Report

C$0.27 +0.01 (+3.85%)
As of 01/20/2025 11:08 AM Eastern

NexgenRx EPS Results

Actual EPS
C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NexgenRx Revenue Results

Actual Revenue
$4.29 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NexgenRx Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

NexgenRx Earnings Headlines

Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
NexgenRX Inc.
Closing Bell: Nexgenrx Inc up on Monday (NXG)
See More NexgenRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NexgenRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NexgenRx and other key companies, straight to your email.

About NexgenRx

NexgenRx (CVE:NXG) administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

View NexgenRx Profile

More Earnings Resources from MarketBeat